Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
boston
boston blog main
boston top stories
clinical trials
national top stories
startups
480 biomedical
acute myeloid leukemia
adverum biotechnologies
ally bridge group
ambit biosciences
arsenal medical
athena countouriotis
big data analytics
blackrock
bob langer
brett zbar
bristol-myers squibb
casdin capital
chronic rhinosinusitis
cormorant asset management
covid-19
daiichi sankyo
deals
diabetic nephropathy
drug delivery
eventide asset management
fda
focal segmental glomerulosclerosis
genzyme
george whitesides
goldfinch bio
halozyme therapeutics
hbm healthcare investments
hbm partners
inflammation
investing
What
biotech
3
×
million
3
×
new
3
×
raised
company
drug
ipo
raises
therapeutics
analysis
athena
bio
bring
cancer
ceo
chief
countouriotis
debut
develop
developing
diseases
employing
financing
genetic
gets
goldfinch
kidney
late
later
lead
lyra
markets
medical
medicines
mezzanine
names
nose
noses
officer
old
Language
unset
Current search:
biotech
×
new
×
million
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push